Cordaro, Marika
Siracusa, Rosalba
Impellizzeri, Daniela
D’ Amico, Ramona
Peritore, Alessio Filippo
Crupi, Rosalia
Gugliandolo, Enrico
Fusco, Roberta
Di Paola, Rosanna
Schievano, Carlo
Cuzzocrea, Salvatore http://orcid.org/0000-0001-6131-3690
Article History
Received: 28 May 2019
Accepted: 1 November 2019
First Online: 28 November 2019
Ethics approval and consent to participate
: The study was approved by the University of Messina Review Board for the care of animals. Animal care was in accordance with Italian regulations on protection of animals used for experimental and other scientific purposes (D.M.116192) as well as with EEC regulations (O.J. of E.C. L 358/1 12/18/1986) and in compliance with the requirements of Italian Legislative Decree no. 26/2014 and subsequent guidelines issued by the Italian Ministry of Health on March 16, 2015.
: Not applicable.
: Dr. Salvatore Cuzzocrea, researcher on the study team, is co-inventor on patent WO2013121449A8 (Epitech Group SpA) which deals with compositions and methods for the modulation of amidases capable of hydrolysing <i>N</i>-acylethanolamines applied in the therapy of inflammatory diseases. Moreover, Dr. Cuzzocrea is also a co-inventor with Epitech group on the following patent:1. EP2821,0832. MI2014A0014953. 102015000067344The other authors declare that they have no competing interests.